MEDPACE HOLDINGS, INC.
MEDP · NASDAQ
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace's mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages regulatory and therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 3,400 people across 37 countries.
Market Data
Price
$418.66
+5.07 (+1.23%)
Market Cap$11.96B
P/E Ratio25.97
EPS$—
52W High$628.92
52W Low$284.10
Beta1.18
Data from Finnhub · Updated May 1, 2026